CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sep. 5, 2013--
Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
provide an overview of the Company’s business at two upcoming investor
conferences being held next week:
The Morgan Stanley Global Healthcare Conference in New York City.
Harvey J. Berger, M.D., chairman and chief executive officer, will
present on Wednesday, September 11 at 1:30 p.m. (ET).
The Stifel Healthcare Conference in Boston. Timothy P. Clackson,
Ph.D., president of research and development and chief scientific
officer, will present on Wednesday, September 11 at 8:35 a.m. (ET).
Both presentations will be webcast live and can be accessed by visiting
the investor relations section of the Company's website at http://www.ariad.com/investor.
A replay of the presentation will also be available and archived on the
site for three weeks.
ARIAD Pharmaceuticals, Inc., headquartered in Cambridge, Massachusetts
and Lausanne, Switzerland, is an integrated global oncology company
focused on transforming the lives of cancer patients with breakthrough
medicines. ARIAD is working on new medicines to advance the treatment of
various forms of chronic and acute leukemia, lung cancer and other
difficult-to-treat cancers. ARIAD utilizes computational and structural
approaches to design small-molecule drugs that overcome resistance to
existing cancer medicines. For additional information, visit http://www.ariad.com
or follow ARIAD on Twitter (@ARIADPharm).
Source: ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc.
Liza Heapes, 617-621-2315